EP3140318
KV1.3 KALÍUMGANGALOKAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.5.2015EP published:
30.10.2019EP application number:
15721694.6
EP translation filed:
23.12.2019Grant published:
15.1.2020EPO information:
European Patent Register
Max expiry date:
6.5.2035Expiry date:
6.5.2026Next due date:
31.5.2026
Title:
KV1.3 POTASSIUM CHANNEL ANTAGONISTS
Timeline
Today
7.5.2015EP application
30.10.2019EP Publication
23.12.2019Translation submitted
15.1.2020Registration published
6.5.2026Expires
Owner
Name:
selectION Therapeutics GmbHAddress:
Am Klopferspitz 19, 82152, Martinsried, DE
Inventor
Name:
KLOSTERMANN, AndreasAddress:
Martinsried, DE
Name:
STOCKHAUS, JörgAddress:
Martinsried, DE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201408135Date:
8.5.2014Country:
GB
Classification
Categories:
C07K 14/47
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 15.5.2020
Expires: 6.5.2021
Payer: Patice ehf.
Number: 7
Paid: 17.5.2021
Expires: 6.5.2022
Payer: Patice ehf.
Number: 8
Paid: 16.5.2022
Expires: 6.5.2023
Payer: Patice ehf.
Number: 9
Paid: 24.5.2023
Expires: 6.5.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 16.5.2024
Expires: 6.5.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 16.5.2025
Expires: 6.5.2026
Payer: Árnason Faktor ehf.